Drugs / CBD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05969314 | Jun 2022 → Jun 2025 overdue | breast cancer, oral cavity squamous cell carcinoma | Tata Memorial Hospital | Active not recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CBD | “5 mg of THC and CBD each” NCT05969314 ↗ |